D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Immunology D-index 50 Citations 7,321 128 World Ranking 2795 National Ranking 22

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Immune system
  • Antibody

His primary scientific interests are in Immunology, Antibody, Internal medicine, Immune system and Endocrinology. His Immunology research focuses on subjects like Molecular biology, which are linked to β2 glycoprotein i. The Antibody study combines topics in areas such as Immunohistochemistry, LDL receptor and Endothelial stem cell.

His Cellular immunity study in the realm of Immune system interacts with subjects such as Heat shock protein. His Endocrinology study combines topics from a wide range of disciplines, such as Morning, Beta 2-Glycoprotein I and Immunization, Antigen. His Autoantibody study incorporates themes from Healthy subjects and Pathology.

His most cited work include:

  • Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus (343 citations)
  • Hyperimmunization of apo-E-deficient mice with homologous malondialdehyde low-density lipoprotein suppresses early atherogenesis (274 citations)
  • Immunolocalization of β2-Glycoprotein I (Apolipoprotein H) to Human Atherosclerotic Plaques Potential Implications for Lesion Progression (238 citations)

What are the main themes of his work throughout his whole career to date?

Boris Gilburd mainly investigates Immunology, Antibody, Autoantibody, Internal medicine and Autoimmunity. His works in Immune system, Autoimmune disease, Antigen, Anti-nuclear antibody and Pathogenesis are all subjects of inquiry into Immunology. His Antibody research includes themes of Systemic lupus erythematosus and Virology.

His research in Autoantibody intersects with topics in Molecular mimicry, Primary biliary cirrhosis, Pathology, Immunoassay and Thrombosis. Boris Gilburd has researched Internal medicine in several fields, including Gastroenterology, Endocrinology and Cardiology. His work deals with themes such as Immunoglobulin G, Guillain-Barre syndrome and Anti-SSA/Ro autoantibodies, which intersect with Autoimmunity.

He most often published in these fields:

  • Immunology (76.44%)
  • Antibody (54.60%)
  • Autoantibody (45.40%)

What were the highlights of his more recent work (between 2017-2021)?

  • Autoantibody (45.40%)
  • Immunology (76.44%)
  • Internal medicine (33.33%)

In recent papers he was focusing on the following fields of study:

Boris Gilburd mostly deals with Autoantibody, Immunology, Internal medicine, Antibody and Autoimmunity. His work on Anti-nuclear antibody as part of general Autoantibody study is frequently linked to Cost of illness, Angiotensin receptor and Hearing loss, therefore connecting diverse disciplines of science. Boris Gilburd performs multidisciplinary studies into Immunology and Mechanism in his work.

His Internal medicine research integrates issues from Gastroenterology and Depression. His biological study spans a wide range of topics, including Adult patients, Uveitis and Antigen. His Autoimmunity research focuses on Systemic lupus erythematosus and how it relates to Immune complex deposition and Autoimmune disease.

Between 2017 and 2021, his most popular works were:

  • Prevalence of anti-DFS70 antibodies in patients with and without systemic autoimmune rheumatic diseases. (41 citations)
  • Vimentin as antigenic target in autoimmunity: A comprehensive review. (34 citations)
  • Antinuclear antibodies: Is the indirect immunofluorescence still the gold standard or should be replaced by solid phase assays? (17 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Immune system
  • Antibody

His primary areas of study are Autoantibody, Anti-nuclear antibody, Immunology, Antibody and IIf. Boris Gilburd regularly ties together related areas like Autoimmunity in his Autoantibody studies. Autoimmunity is a subfield of Internal medicine that Boris Gilburd investigates.

His Anti-nuclear antibody research is multidisciplinary, relying on both Molecular biology and Indirect immunofluorescence. His biological study focuses on Antibody titer. His work is dedicated to discovering how IIf, Immunoadsorption are connected with Seroepidemiologic Studies and Immunoassay and other disciplines.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus

A Doria;Y Shoenfeld;R Wu;P F Gambari.
Annals of the Rheumatic Diseases (2003)

486 Citations

Hyperimmunization of apo-E-deficient mice with homologous malondialdehyde low-density lipoprotein suppresses early atherogenesis

Jacob George;Arnon Afek;Boris Gilburd;Hana Levkovitz;Hana Levkovitz.
Atherosclerosis (1998)

419 Citations

Immunolocalization of β2-Glycoprotein I (Apolipoprotein H) to Human Atherosclerotic Plaques Potential Implications for Lesion Progression

Jacob George;Dror Harats;Boris Gilburd;Arnon Afek.
Circulation (1999)

364 Citations

Induction of Early Atherosclerosis in LDL-Receptor–Deficient Mice Immunized With β2-Glycoprotein I

Jacob George;Arnon Afek;Boris Gilburd;Miri Blank.
Circulation (1998)

333 Citations

Enhanced Fatty Streak Formation in C57BL/6J Mice by Immunization With Heat Shock Protein-65

Jacob George;Yehuda Shoenfeld;Arnon Afek;Boris Gilburd.
Arteriosclerosis, Thrombosis, and Vascular Biology (1999)

292 Citations

Oral tolerance with heat shock protein 65 attenuates mycobacterium tuberculosis-inducedand high-fat-diet-driven atherosclerotic lesions

Dror Harats;Niva Yacov;Boris Gilburd;Yehuda Shoenfeld.
Journal of the American College of Cardiology (2002)

266 Citations

Adoptive Transfer of β2-Glycoprotein I–Reactive Lymphocytes Enhances Early Atherosclerosis in LDL Receptor–Deficient Mice

Jacob George;Dror Harats;Boris Gilburd;Arnon Afek.
Circulation (2000)

249 Citations

The mosaic of autoimmunity: hormonal and environmental factors involved in autoimmune diseases--2008.

Yehuda Shoenfeld;Gisele Zandman-Goddard;Ljudmila Stojanovich;Maurizio Cutolo.
Israel Medical Association Journal (2008)

222 Citations

Immunization with anticardiolipin cofactor (beta-2-glycoprotein I) induces experimental antiphospholipid syndrome in naive mice

Miri Blank;David Faden;Angela Tincani;Juri Kopolovic.
Journal of Autoimmunity (1994)

206 Citations

The mosaic of autoimmunity: prediction, autoantibodies, and therapy in autoimmune diseases--2008.

Yehuda Shoenfeld;Miri Blank;Mahmoud Abu-Shakra;Mahmoud Abu-Shakra;Howard Amital.
Israel Medical Association Journal (2008)

183 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Boris Gilburd

Yehuda Shoenfeld

Yehuda Shoenfeld

Sheba Medical Center

Publications: 453

Miri Blank

Miri Blank

Sheba Medical Center

Publications: 84

Yaniv Sherer

Yaniv Sherer

Ben-Gurion University of the Negev

Publications: 62

Eiji Matsuura

Eiji Matsuura

Okayama University

Publications: 62

Nancy Agmon-Levin

Nancy Agmon-Levin

Sheba Medical Center

Publications: 57

Pier Luigi Meroni

Pier Luigi Meroni

Istituto Auxologico Italiano

Publications: 53

Jan Nilsson

Jan Nilsson

Lund University

Publications: 49

Howard Amital

Howard Amital

Sheba Medical Center

Publications: 47

Angela Tincani

Angela Tincani

University of Brescia

Publications: 43

Gisele Zandman-Goddard

Gisele Zandman-Goddard

Wolfson Medical Center

Publications: 40

Andrea Doria

Andrea Doria

University of Padua

Publications: 39

Prediman K. Shah

Prediman K. Shah

Cedars-Sinai Medical Center

Publications: 39

Göran K. Hansson

Göran K. Hansson

Karolinska University Hospital

Publications: 38

Marvin J. Fritzler

Marvin J. Fritzler

University of Calgary

Publications: 35

Johan Frostegård

Johan Frostegård

Karolinska Institute

Publications: 29

Christoph J. Binder

Christoph J. Binder

Medical University of Vienna

Publications: 28

Trending Scientists

Peter E. Hart

Peter E. Hart

Independent Scientist / Consultant, US

Emiel J. M. Hensen

Emiel J. M. Hensen

Eindhoven University of Technology

Giulio Malucelli

Giulio Malucelli

Polytechnic University of Turin

Brian K. Kennedy

Brian K. Kennedy

National University of Singapore

Shao Jian Zheng

Shao Jian Zheng

Zhejiang University

Alexander D. Verin

Alexander D. Verin

Augusta University

Josefina Liñares

Josefina Liñares

University of Barcelona

Lynton S. Land

Lynton S. Land

The University of Texas at Austin

Mike Lucas

Mike Lucas

University of Cape Town

Helen Hodges

Helen Hodges

ReNeuron (United Kingdom)

Kris Thielemans

Kris Thielemans

Vrije Universiteit Brussel

Larry Nucci

Larry Nucci

University of California, Berkeley

Bo Vinnerljung

Bo Vinnerljung

Stockholm University

Benson Honig

Benson Honig

McMaster University

Daniel E. Reichart

Daniel E. Reichart

University of North Carolina at Chapel Hill

Yu G. Kolomensky

Yu G. Kolomensky

University of California, Berkeley

Something went wrong. Please try again later.